Author

Karen Chak

Observed names: K Chak, K. Chak

Institutions: Chinese University of Hong Kong, Prince of Wales Hospital, State Key Laboratory of Oncology in South China

Observed institutions: Eli Lilly (United States), Chinese University of Hong Kong, Prince of Wales Hospital, State Key Laboratory of Oncology in South China, University of Birmingham

OpenAlex ID: A5031663725

A double-blind placebo-controlled randomized study of Chinese herbal medicine as complementary therapy for reduction of chemotherapy-induced toxicity

2007 · T.S.K. Mok, W. Yeo, et al. · Annals of Oncology · 97

A multi-centre randomized phase II study of nolatrexed versus doxorubicin in treatment of Chinese patients with advanced hepatocellular carcinoma

1999 · Tony S. K. Mok, Thomas W. T. Leung, et al. · Cancer Chemotherapy and Pharmacology · 47

Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma

2001 · Tony S. K. Mok, Sarath Kanekal, et al. · Cancer · 30

A Phase I–II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma

2002 · Tony S. K. Mok, Herman Wong, et al. · Cancer · 25

Phase II Randomized Study Comparing the Toxicity Profile of Gemcitabine plus Cisplatin with Gemcitabine plus Oral Etoposide in the Treatment of Advanced Non-Small Cell Lung Cancer

2005 · Tony S.K. Mok, Kwok Chi Lam, et al. · Oncology · 14

A phase I safety and pharmacokinetic study of OGT 719 in patients with liver cancer

2004 · Tony S. K. Mok, Thomas W. T. Leung, et al. · Acta Oncologica · 8

Clinical outcomes of post-operative locoregional radiotherapy in pre-menopausal and post-menopausal Chinese women with breast cancer

2000 · Tony S.K Mok, Wing Hong Kwan, et al. · Radiotherapy and Oncology · 6

Sequential Chemotherapy with Combination Irinotecan and Cisplatin Followed by Docetaxel for Treatment-Naïve Patients with Advanced Non-small Cell Lung Cancer

2007 · Tony S.K. Mok, Simon Ho, et al. · Journal of Thoracic Oncology · 2

Gemcitabine-based combination chemotherapy for advanced non-small cell lung cancer: A new generation of therapy without cisplatin

2000 · T Mok, B Nguyen, et al. · Lung Cancer · 1

P-832 Chinese herbal medicine (CHM) induces immuno-modulation in patients with advanced stage non-small lung cancer (NSCLC): A double-blind placebo-control randomized study

2005 · T. Mok, C. Wong, et al. · Lung Cancer

A double-blind placebo-control randomized study of the efficacy of Chinese herbal medicine (CHM) in reduction of cytotoxic chemotherapy-induced toxicity

2005 · T. Mok, W. Yeo, et al. · Journal of Clinical Oncology

Acknowledgement to the Reviewers

2005 · Chih-Hung Hsu, Kun-Huei Yeh, et al. · Oncology

Author Index Vol. 68, 2005

2005 · Chih-Hung Hsu, Kun-Huei Yeh, et al. · Oncology

A phase II study of gemcitabine plus oral etoposide (GOE) in treatment of advanced non-small cell lung cancer

1999 · T.S.K. Mok, A.T.C. Chan, et al. · European Journal of Cancer

Works count: 14

Citation count: 230

H-index: 6

I10-index: 5